Vicente Alberola Candel

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.

R.P. Carrion, Vicente Alberola Candel, F. Calabresi et al. · PubMed · 1994 · 99 citations

Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients

Joan Manel Gasent Blesa, Vicente Giner Marco, Vicent Giner‐Bosch et al. · American Journal of Clinical Oncology · 2010 · 22 citations · Full text

Old and New Insights in the Treatment of Thyroid Carcinoma

Joan Manel Gasent Blesa, Enrique Grande Pulido, Mariano Provencio et al. · Journal of Thyroid Research · 2010 · 14 citations · Full text

Tumor Biology, Thyroid Carcinoma, Medicine +15

Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer

Joan Manel Gasent Blesa, J. Garde, Juan Bautista Laforga Canales et al. · Journal of Gastrointestinal Cancer · 2012 · 11 citations

Surgical Oncology, Phase Ii Trial, Radiation Therapy +9

Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study

Jesús González‐Barboteo, Xavier Gómez-Batiste Alentorn, Felipe A. Calvo et al. · Journal of Opioid Management · 2014 · 11 citations